Jidong Jia

ORCID: 0000-0002-9407-8890
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Hepatitis B Virus Studies
  • Nonlinear Optical Materials Studies
  • Hepatitis C virus research
  • Nonlinear Optical Materials Research
  • Porphyrin and Phthalocyanine Chemistry
  • Liver Disease and Transplantation
  • X-ray Diffraction in Crystallography
  • Crystallization and Solubility Studies
  • Crystallography and molecular interactions
  • Liver physiology and pathology
  • Hepatitis Viruses Studies and Epidemiology
  • Photochromic and Fluorescence Chemistry
  • Luminescence and Fluorescent Materials
  • Photochemistry and Electron Transfer Studies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Liver Diseases and Immunity
  • GDF15 and Related Biomarkers
  • Systemic Lupus Erythematosus Research
  • Organic Electronics and Photovoltaics
  • HIV/AIDS drug development and treatment
  • Diet, Metabolism, and Disease
  • Drug-Induced Hepatotoxicity and Protection
  • Pancreatic and Hepatic Oncology Research
  • Advanced Fiber Laser Technologies

Capital Medical University
2009-2025

Beijing Friendship Hospital
2010-2025

National Clinical Research Center for Digestive Diseases
2020-2025

XinHua Hospital
2024

Shanghai Jiao Tong University
2024

Chinese PLA General Hospital
2024

Huzhou University
2023-2024

National Institute of Diabetes and Digestive and Kidney Diseases
2019-2023

ProQuest (United States)
2019-2023

Harbin Institute of Technology
2020-2022

Devin Razavi‐Shearer Ivane Gamkrelidze Calvin Q. Pan Jidong Jia Thomas Berg and 95 more Richard T. Gray Young‐Suk Lim Chien‐Jen Chen Ponsiano Ocama Hailemichael Desalegn Zaigham Abbas Ayat R. Abdallah Alessio Aghemo Sabohat Ahmadbekova Sang Hoon Ahn Inka Aho Ulus Salih Akarca Nasser Al Masri Abduljaleel Alalwan Seyed Moayed Alavian Said A. Al‐Busafi Soo Aleman Faleh Alfaleh Abdullah Alghamdi Waleed Al–Hamoudi Abdulrahman Aljumah Khalid Al‐Naamani Ahmad Al‐Rifai Yousif Mohamed AlSerkal Ibrahim Altraif Amarsanaa Jazag Motswedi Anderson Monique Andersson Paige A. Armstrong Tarik Asselah Kostas Athanasakis Oidov Baatarkhuu Ziv Ben‐Ari Aïcha Bensalem Fernando Bessone Mia J. Biondi Abdul Rahman Bizri Sarah Blach Wornei Silva Miranda Braga Carlos Eduardo Brandão‐Mello Carol Brosgart Kimberly Brown Robert S. Brown Philip Bruggmann Maurizia Rossana Brunetto Marı́a Buti Joaquín Cabezas Teresa Casanovas Chungman Chae Henry Lik‐Yuen Chan Hugo Cheinquer Pei‐Jer Chen Kent Jason Cheng Myeong-Eun Cheon Cheng‐Hung Chien Gourdas Choudhuri Peer Brehm Christensen Wan‐Long Chuang Vladimir Chulanov Laura Cisneros Carla S. Coffin F. Contreras Nicola Coppola Markus Cornberg Benjamin C Cowie Matthew Cramp Antonio Craxı̀ Javier Crespo Fuqiang Cui Chris Cunningham Olav Dalgård Robert J. de Knegt Victor de Lédinghen Gregory J. Dore Sylvia Dražilová Ann‐Sofi Duberg Steve S Egeonu Mohammed Elbadri Mohamed El‐Kassas Manal H. El‐Sayed Chris Estes Ohad Etzion Elmoubasher Farag Laurent Ferradini Paulo Roberto Abrão Ferreira Robert Flisiak Xavier Forns Soňa Fraňková James Fung Edward Gane Virginia Garcia Javier García‐Samaniego Manik Gemilyan Jordan Genov Liliana Gheorghe

10.1016/s2468-1253(23)00197-8 article EN ˜The œLancet. Gastroenterology & hepatology 2023-07-27

•This is the first prospective validation of Baveno VII recompensation definition in patients with HBV-related cirrhosis.•A stable improvement liver function tests was defined as MELD <10 and/or ALB & INR TBIL within Child-Pugh A.•On-treatment scores may be more predictive probability than baseline scores.•Prompt antiviral therapy effective for cirrhosis, even under severe conditions. Background AimsAntiviral improves clinical outcomes chronic hepatitis B (CHB), including those cirrhosis. In...

10.1016/j.jhep.2022.07.037 article EN cc-by-nc-nd Journal of Hepatology 2022-08-28
Homie Razavi Marı́a Buti Norah A. Terrault Stefan Zeuzem Cihan Yurdaydìn and 86 more Junko Tanaka Alessio Aghemo Ulus Salih Akarca Nasser M. Al Masri Abduljaleel Alalwan Soo Aleman Abdullah S Alghamdi Saad Alghamdi Waleed K. Al‐Hamoudi Abdulrahman Aljumah Ibrahim Altraif Tarik Asselah Ziv Ben‐Ari Thomas Berg Mia J. Biondi Sarah Blach Wornei Silva Miranda Braga Carlos Eduardo Brandão‐Mello Maurizia Rossana Brunetto Joaquín Cabezas Hugo Cheinquer Pei‐Jer Chen Myeong-Eun Cheon Wan‐Long Chuang Carla S. Coffin Nicola Coppola Antonio Craxı̀ Javier Crespo Victor de Lédinghen Ann‐Sofi Duberg Ohad Etzion Maria Lúcia Gomes Ferraz Paulo Roberto Abrão Ferreira Xavier Forns Graham R. Foster Giovanni Battista Gaeta Ivane Gamkrelidze Javier García‐Samaniego Liliana Gheorghe Pierre M. Gholam Robert G. Gish Jeffrey S. Glenn Julian Hercun Yao‐Chun Hsu Ching‐Chih Hu Jee‐Fu Huang Naveed Z. Janjua Jidong Jia Martin Kåberg Kelly Kaita Habiba Kamal Jia‐Horng Kao Loreta A. Kondili Martin Lagging Pablo Lázaro Jeffrey V. Lazarus Mei‐Hsuan Lee Young‐Suk Lim Paul J. Marotta María Cristina Navas Marcelo Contardo Moscoso Naveira Mauricio Orrego Carla Osiowy Calvin Q. Pan Mário G. Pessôa Giovanni Raimondo Alnoor Ramji Devin Razavi‐Shearer Kathryn Razavi‐Shearer Cielo Ríos Manuel Rodríguez William Rosenberg Dominique Roulot Stephen Ryder Rifaat Safadi Faisal M. Sanai Teresa Santantonio Christoph Sarrazin Daniel Shouval Frank Tacke Tammo Lambert Tergast Juan Miguel Villalobos-Salcedo Alexis Voeller Hwai‐I Yang Ming‐Lung Yu Eli Zuckerman

Hepatitis D virus (HDV) infection occurs as a coinfection with hepatitis B and increases the risk of hepatocellular carcinoma, decompensated cirrhosis, mortality compared to (HBV) monoinfection. Reliable estimates prevalence HDV disease burden are essential formulate strategies find coinfected individuals more effectively efficiently. The global HBV infections was estimated be 262,240,000 in 2021. Only 1,994,000 were newly diagnosed 2021, than half new diagnoses made China. Our initial...

10.1016/j.jhep.2023.02.041 article EN cc-by-nc-nd Journal of Hepatology 2023-04-07

Abstract Background The Asia–Pacific (AP) region carries a substantial burden of HBV. Affordable HBV treatment is crucial to attain WHO’s elimination goal. This study assesses the pricing and affordability in AP. Methods A survey conducted among APASL members from 2 Aug 30 Oct, 2023, gathered data on antiviral drugs, costs covering stages chronic hepatitis B (CHB), compensated cirrhosis (CC), hepatocellular carcinoma (HCC), liver transplant, monitoring expenses. Drug for TDF ETV were...

10.1007/s12072-024-10744-9 article EN cc-by Hepatology International 2025-02-03

Abstract Aims This study aims to determine the predictive capability for metabolic dysfunction‐associated steatohepatitis (MASH) long before its diagnosis by using six previously identified diagnostic biomarkers steatotic liver disease (MASLD) with proteomic data from UK Biobank. Materials and Methods A nested case–control comprising a MASH group three age‐ sex‐matched control groups (metabolic steatosis, viral hepatitis normal controls) was conducted. Olink proteomics, anthropometric...

10.1111/dom.16233 article EN Diabetes Obesity and Metabolism 2025-02-05

Intramolecular charge transfer (ICT) is an important factor in the nonlinear optical (NLO) properties of organic molecules. In order to study effect ICT on two-photon absorption (TPA) and excited-state (ESA), three chalcone derivatives (1, 2 3) with different electron push-pull systems were designed synthesized. The performance these depends mainly includes ultrafast femtosecond time domain long-lived state (CTS) picosecond domain, which dominate molecular TPA ESA respectively. Hole-electron...

10.1039/d1cp04567a article EN Physical Chemistry Chemical Physics 2021-12-14

Six analogous two-dimensional (2D) [Tp*WS3Cu3]-based (Tp* = hydridotris(3,5-dimethylpyrazol-1-yl)borate) networks, namely, {[(Tp*WS3Cu3)2L3](μ3-N3)}n (2: L 5-methyltetrazolate (Mtta); 3a: 5-ethyltetrazolate (Etta)) and {[(Tp*WS3Cu3)2L3]BF4}n (3b: Etta; 4: 5-propyltetrazolate (Ptta); 5: 5-butyltetrazolate (Btta); 6: 5-pentyltetrazolate (Petta)) were synthesized by reactions of [Et4N][Tp*WS3] (1), [Cu(CH3CN)4]BF4, NaN3, NH4BF4 in different nitrile solvents (CH3(CH2)nCN, n 0, 1, 2, 3, 4) under...

10.1021/acs.inorgchem.7b00261 article EN Inorganic Chemistry 2017-04-26

Two simple hydrazone derivatives (A1 and A2) linked with different Π-conjugated systems are designed synthesized to reach ultrafast broad-band optical limiting (OL) under pulse widths. To exploit various virtues of two-photon absorption (TPA)-induced excited-state (TPA–ESA), ESA is successfully established on a singlet state. Both compounds show range from 556 750 nm relatively long lifetime. A1 displays larger reverse saturable than A2 in the multiwavelength Z-scan experiments. Furthermore,...

10.1021/acs.jpcc.8b02149 article EN The Journal of Physical Chemistry C 2018-06-26

We report a case of 62-year old woman admitted to our hospital for multiple nodular metastatic liver lesions found by ultrasonography in regular medical examination.Routine laboratory tests were normal.PET-CT showed bone and lesions.Liver biopsy revealed infiltration myeloma with positive staining kappa light chain.Further investigation marrow aspiration, immunofixation immunoelectrophoresis serum protein, urine test Bence-Jones β2-microglobulin confirmed the diagnosis.The patient also...

10.3748/wjg.15.1014 article EN cc-by-nc World Journal of Gastroenterology 2009-01-01

Hypercoagulability, hemodynamic changes, and endothelial injury are the three major contributors to development of thrombosis. However, role hypercoagulability in portal vein thrombosis (PVT) liver cirrhosis is still controversial. The aim this study elucidate relationship between procoagulant imbalance PVT patients with cirrhosis.This included 151 (n=20) or without (n=131). Levels factor (FVIII) anticoagulants [protein C (PC), protein S (PS), antithrombin (AT)] were measured. Procoagulant...

10.1097/meg.0000000000000352 article EN European Journal of Gastroenterology & Hepatology 2015-04-08
Coming Soon ...